Engel AG - Search Results

1

Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome.

Harper CM, Engel AG. Harper CM, et al. Among authors: engel ag. Ann N Y Acad Sci. 1998 May 13;841:203-6. doi: 10.1111/j.1749-6632.1998.tb10929.x. Ann N Y Acad Sci. 1998. PMID: 9668241 Clinical Trial. No abstract available.

2

Myasthenic syndrome caused by mutation of the SCN4A sodium channel.

Tsujino A, Maertens C, Ohno K, Shen XM, Fukuda T, Harper CM, Cannon SC, Engel AG. Tsujino A, et al. Among authors: engel ag. Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7377-82. doi: 10.1073/pnas.1230273100. Epub 2003 May 23. Proc Natl Acad Sci U S A. 2003. PMID: 12766226 Free PMC article.

3

Treatment of slow-channel congenital myasthenic syndrome with fluoxetine.

Harper CM, Fukodome T, Engel AG. Harper CM, et al. Among authors: engel ag. Neurology. 2003 May 27;60(10):1710-3. doi: 10.1212/01.wnl.0000061483.11417.1b. Neurology. 2003. PMID: 12771277

4

Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel.

Engel AG, Uchitel OD, Walls TJ, Nagel A, Harper CM, Bodensteiner J. Engel AG, et al. Ann Neurol. 1993 Jul;34(1):38-47. doi: 10.1002/ana.410340109. Ann Neurol. 1993. PMID: 7685992

5

Congenital myasthenic syndromes: I. Deficiency and short open-time of the acetylcholine receptor.

Engel AG, Nagel A, Walls TJ, Harper CM, Waisburg HA. Engel AG, et al. Muscle Nerve. 1993 Dec;16(12):1284-92. doi: 10.1002/mus.880161204. Muscle Nerve. 1993. PMID: 8232383

6

Congenital end-plate acetylcholine receptor deficiency and short channel open time.

Nagel A, Engel AG, Walls TJ, Harper CM, Waisburg HA. Nagel A, et al. Among authors: engel ag. Ann N Y Acad Sci. 1993 Jun 21;681:509-14. doi: 10.1111/j.1749-6632.1993.tb22934.x. Ann N Y Acad Sci. 1993. PMID: 8357192 No abstract available.

7

Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release.

Walls TJ, Engel AG, Nagel AS, Harper CM, Trastek VF. Walls TJ, et al. Among authors: engel ag. Ann N Y Acad Sci. 1993 Jun 21;681:461-8. doi: 10.1111/j.1749-6632.1993.tb22930.x. Ann N Y Acad Sci. 1993. PMID: 8395161 No abstract available.

8

The spectrum of congenital end-plate acetylcholinesterase deficiency.

Hutchinson DO, Engel AG, Walls TJ, Nakano S, Camp S, Taylor P, Harper CM, Brengman JM. Hutchinson DO, et al. Among authors: engel ag. Ann N Y Acad Sci. 1993 Jun 21;681:469-86. doi: 10.1111/j.1749-6632.1993.tb22931.x. Ann N Y Acad Sci. 1993. PMID: 8395162 No abstract available.

9

Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome.

Harper CM, Engel AG. Harper CM, et al. Among authors: engel ag. Ann Neurol. 1998 Apr;43(4):480-4. doi: 10.1002/ana.410430411. Ann Neurol. 1998. PMID: 9546329 Clinical Trial.

10

Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.

Ohno K, Engel AG, Shen XM, Selcen D, Brengman J, Harper CM, Tsujino A, Milone M. Ohno K, et al. Among authors: engel ag. Am J Hum Genet. 2002 Apr;70(4):875-85. doi: 10.1086/339465. Epub 2002 Jan 14. Am J Hum Genet. 2002. PMID: 11791205 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

398 results

Search Page